Clinical Trial Update: Switch From Tacrolimus to Cyclosporin in the Treatment of Recurrent Hepatitis C After Liver Transplantation [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating switching from tacrolimus to cyclosporin for recurrent hepatitis C after liver transplantation was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Cyclosporin (cyclosporine)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Rennes University Hospital | Conditions: Chronic Hepatitis C, Evidence of Liver Transplantation | Phase 3 | Status: TERMINATED